Idiopathic pulmonary fibrosis: Current and future treatment
DS Glass, D Grossfeld, HA Renna… - The clinical …, 2022 - Wiley Online Library
Objectives Idiopathic pulmonary fibrosis (IPF) is a chronic fibrotic lung disease characterized
by dry cough, fatigue, and progressive exertional dyspnea. Lung parenchyma and …
by dry cough, fatigue, and progressive exertional dyspnea. Lung parenchyma and …
Impact of antifibrotic therapy on mortality and acute exacerbation in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Background Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung
disease associated with significant morbidity and mortality. Nintedanib and pirfenidone are …
disease associated with significant morbidity and mortality. Nintedanib and pirfenidone are …
[HTML][HTML] Antifibrotics and reduced mortality in idiopathic pulmonary fibrosis: immortal time bias
S Suissa, K Suissa - American Journal of Respiratory and Critical …, 2023 - atsjournals.org
1. Khor YH, Ng Y, Barnes H, Goh NSL, McDonald CF, Holland AE. Prognosis of idiopathic
pulmonary fibrosis without anti-fibrotic therapy: a systematic review. Eur Respir Rev 2020; …
pulmonary fibrosis without anti-fibrotic therapy: a systematic review. Eur Respir Rev 2020; …
[HTML][HTML] A systematic review of the prognostic significance of the body mass index in idiopathic pulmonary fibrosis
The identification of novel prognostic biomarkers might enhance individualized
management strategies in patients with idiopathic pulmonary fibrosis (IPF). Although several …
management strategies in patients with idiopathic pulmonary fibrosis (IPF). Although several …
Physical activity, exercise capacity and mortality risk in people with interstitial lung disease: A systematic review and meta-analysis
Objectives Physical activity and exercise measures show potential to predict mortality in
people with interstitial lung disease. This study summarized evidence on the association …
people with interstitial lung disease. This study summarized evidence on the association …
[HTML][HTML] Real-world clinical outcomes based on body Mass Index and annualized weight change in patients with idiopathic pulmonary fibrosis
JS Lee, A Martin-Schwarze, E Freiheit, B Trzaskoma… - Advances in …, 2023 - Springer
Introduction Identification of clinical characteristics associated with prognosis for idiopathic
pulmonary fibrosis (IPF) may help to guide management decisions. This analysis utilized …
pulmonary fibrosis (IPF) may help to guide management decisions. This analysis utilized …
[HTML][HTML] Acute exacerbation in interstitial lung disease
EH Alhamad, JG Cal, NN Alrajhi… - Annals of Thoracic …, 2021 - journals.lww.com
BACKGROUND: Information regarding acute exacerbation (AE) in patients with interstitial
lung disease (ILD) is limited. OBJECTIVES: The objective of the study was to elucidate the …
lung disease (ILD) is limited. OBJECTIVES: The objective of the study was to elucidate the …
[HTML][HTML] The influence of immortal time bias in observational studies examining associations of antifibrotic therapy with survival in idiopathic pulmonary fibrosis: A …
Q Zheng, P Otahal, IA Cox, B de Graaff… - Frontiers in …, 2023 - frontiersin.org
Background Immortal time bias (ITB) has been overlooked in idiopathic pulmonary fibrosis
(IPF). We aimed to identify the presence of ITB in observational studies examining …
(IPF). We aimed to identify the presence of ITB in observational studies examining …
[HTML][HTML] Investigation of clinical predictors of survival in idiopathic pulmonary fibrosis patients: a cohort study in Taiwan
CM Tseng, MY Chen, CY Kao… - Journal of the Chinese …, 2022 - journals.lww.com
Background: Two antifibrotic medications, pirfenidone and nintedanib, have been approved
as treatments for idiopathic pulmonary fibrosis (IPF)—a life-threatening interstitial lung …
as treatments for idiopathic pulmonary fibrosis (IPF)—a life-threatening interstitial lung …
Body mass index and weight loss as risk factors for poor outcomes in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis
X He, J Ji, C Liu, Z Luo, J Tang, H Yan, L Guo - Annals of Medicine, 2024 - Taylor & Francis
Objective The association between nutritional status and prognosis of idiopathic pulmonary
fibrosis (IPF) remains unclear. This systematic review and meta-analysis aimed to explore …
fibrosis (IPF) remains unclear. This systematic review and meta-analysis aimed to explore …